Biomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :
The MILLIPLEX® MAP Human Liver Protein Magnetic Bead Panel is used for the simultaneous quantification of the following Human analytes: AFP, ANGPTL3, ANGPTL4, ANGPTL6/AGF, FABP1, FGF-19, FGF-21, FGF-23, HGF
The MILLIPLEX® MAP Human Metabolic Hormone Panel is used for the simultaneous quantification of the following Human analytes: Amylin (Active), Amylin (Total), C-Peptide, GIP (Total), GLP-1 (Active), Ghrelin (Active), Glucagon, IL-6, Insulin, Leptin, MCP-1, PP, PYY, TNF-α
The MILLIPLEX® MAP Human Metabolic Hormone Magnetic Bead Panel is used for the simultaneous quantification of the following Human analytes: Amylin (Total), Amylin (Active), C-Peptide, Ghrelin (Active), GIP (Total), GLP-1 (Active), Glucagon, IL-6, Insulin, Leptin, MCP-1, PP, PYY, TNF-α
The MILLIPLEX® MAP Human MMP Panel 1 is used for the simultaneous quantification of the following Human analytes: MMP-3, MMP-12, MMP-13
The MILLIPLEX® MAP Human MMP Panel 2 is used for the simultaneous quantification of the following Human analytes: MMP-1, MMP-2, MMP-7, MMP-9, MMP-10
The MILLIPLEX® MAP Human Neurodegenerative Disease Panel 1 is used for the simultaneous quantification of the following Human analytes: Apo Al, Apo CIII, Apo E, Complement C3, Complement Factor H, Prealbumin, α2-Macroglobulin
The MILLIPLEX® MAP Human Neurodegenerative Disease Panel 2 is used for the simultaneous quantification of the following Human analytes: CRP, Complement C4, MIP-4, PEDF, SAP, α1-Antitrypsin
The MILLIPLEX® MAP Human Neurodegenerative Disease Panel 3 is used for the simultaneous quantification of the following Human analytes: BDNF, Caathepsin D, MPO, NCAM, PAI-1 (total), PDGF-AA, PDGF-AB/BB, RANTES, sICAM-1, sVCAM-1
The MILLIPLEX® MAP Human Neurodegenerative Disease Panel 4 is used for the simultaneous quantification of the following Human analytes: Amyloid β40, Amyloid β42, GDNF, S100B, sRAGE
The MILLIPLEX® MAP Human Neuropeptide Panel is used for the simultaneous quantification of the following Human analytes: Cortisol, Melatonin, Neurotensin, Orexin A, Oxytocin, Substance P, α-MSH, β-Endorphin
